EUROPEAN shares declined on Tuesday as Airbus tumbled after a profit warning and sparked an aerospace-related sell-off, while investors focused on French parliamentary elections later in the week.
The continent-wide Stoxx 600 ended 0.2 per cent lower.
Airbus tumbled 9.4 per cent and was among the biggest drags on the index, after Europe’s largest aerospace group cut its industrial and financial targets and took a hefty 900 million euro (S$1.31 billion) charge for its space activities.
Its profit warning and forecast for fewer plane deliveries dragged jet-engine manufacturers Rolls-Royce and MTU Aero Engines lower.
The wider Stoxx Europe aerospace and defence index slid 3.8 per cent to its lowest in over three months.
The tech sub-index, which houses some of Europe’s biggest chip-related firms, rebounded from near three-week lows earlier in the session to close 0.2 per cent higher.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Chipmakers are among the best-performing sectors in Europe, with the index jumping 15% so far this year.
“We’re seeing a pretty healthy broadening of a longer-term equity rally.” said Tom Gehlen, senior market strategist at SG Kleinwort Hambros. “Tech stocks had an amazing run and it’s nothing but healthy that they’re taking a bit of a pause giving opportunity to investors to catch their breath and reposition.”
The market remains focused on the first round of French parliamentary elections and a key US inflation report due later this week.
Paris stock market operator Euronext’s CEO said the prospect of a politically extreme party with little or no government experience reaching power is worrying investors.
“(Polls) suggest that the centre will be depopulated as voters swing to the extremes on the left and right,” economists at Pantheon Macroeconomics noted.
“We think the main outcome of such a result is political stalemate rather than crisis, but the stakes are high for France and Europe alike.”
France’s benchmark CAC 40 slipped 0.6 per cent amidst the broader sell-off.
Among other stocks, Germany’s Merck shed 5.7 per cent after the drugmaker said it had stopped trials for Xevinapant in advanced head and neck cancer.
French lab testing firm Eurofins gained 4 per cent after falling as much as 25 per cent on Monday when short seller Muddy Waters took a short position in the company.
Novo Nordisk’s shares advanced 4 per cent to a record high after the Danish pharmaceutical giant said its weight-loss drug Wegovy had been approved in China. REUTERS
